Skip to main content
Fig. 1 | Molecular Medicine

Fig. 1

From: Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illness

Fig. 1

– Soluble BTLA in Critical Illness: SBTLA is increased in the serum of mice (Figure a, p = 0.0037) and humans (Figure b, p < 0.001), but no differences were seen in the BAL fluid of mice (p = 0.476, Figure c), and changes in critically ill patient levels of sBTLA on day 0 of hospital admission predict the diagnosis of sepsis (Figure d)

Back to article page

Molecular Medicine

ISSN: 1528-3658